Role and mechanism of ASGR1 in acute liver injury
Life Sciences · 2026
DOI: 10.1016/j.lfs.2025.124157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Lingli Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, China. Hauptthemen laut MEDLINE: Asialoglycoprotein Receptor, Liver Diseases. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
AIMS: ASGR1 is a hepatocyte surface glycoprotein receptor that plays a crucial role in maintaining liver homeostasis. This study investigates its role in acute liver injury (ALI) and whether it is associated with the regulation of PANoptosis-like pathway. MATERIALS AND METHODS: An LPS/D-Gal-induced ALI model was established using ASGR1 knockout mice. Liver function, inflammation, oxidative stress, mitochondrial function, and PANoptosis-like markers were assessed. In vitro studies on primary hepatocytes examined the effects of ASGR1 knockout or overexpression on ALI, with the ROS inhibitor NAC and NOXs inhibitor DPI used to explore underlying mechanisms. KEY FINDINGS: In the ALI model, ASGR1 expression was decreased, and ASGR1-/- mice showed lower survival, more severe liver injury, and higher inflammatory cytokine levels. Electron microscopy revealed pronounced cell death-associated morphological changes in ASGR1-/- hepatocytes under ALI. Using multiple cell death inhibitors, we confirmed that apoptosis and necroptosis were the predominant death modalities, consistent with increased BAX/BCL-2 ratio, cleaved caspase-8, p-RIPK1, p-RIPK3, and p-MLKL. Proteomic analysis revealed that the differentially expressed proteins were predominantly enriched in pathways related to oxidative stress and mitochondrial function. ASGR1 deficiency in ALI led to elevated ROS levels and a marked reduction in mitochondrial membrane potential, both of which were reversed by NOXs inhibition. Importantly, scavenging ROS and inhibiting NOXs substantially mitigated the activation of the PANoptosis-like pathway induced by ASGR1 deficiency. SIGNIFICANCE: ASGR1 downregulation aggravates ALI via the NOXs-ROS-PANoptosis-like axis, underscoring the pivotal role of ASGR1 in ALI progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
- Phase I Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008…
- Department of Anesthesiology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
- Department of Emergency, The Third Xiangya Hospital of Central South University, Changsha, 410013, China.
- Department of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, 410013, China. Electronic address: pharmguor@csu.edu.cn.
Förderung
- Hunan Provincial Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Huang, L., Wang, Y., Li, D., Gao, G., Wu, H., Zeng, Y., Zhang, S., Chen, Z., Guo, R., & Chen, R. (2026). Role and mechanism of ASGR1 in acute liver injury. Life Sciences. https://doi.org/10.1016/j.lfs.2025.124157
Vancouver
Huang L, Wang Y, Li D, Gao G, Wu H, Zeng Y, et al. Role and mechanism of ASGR1 in acute liver injury. Life Sciences. 2026. doi:10.1016/j.lfs.2025.124157
BibTeX
@article{Huang2026,
author = {Huang, Lingli and Wang, Yanshi and Li, Dai and Gao, Ge and Wu, Hui and Zeng, Youjie and Zhang, Siyi and Chen, Ziying and Guo, Ren and Chen, Ruifang},
title = {Role and mechanism of ASGR1 in acute liver injury},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2025.124157}
}
EUVIMED